Archived explainer. For the current picture see today's UNH page.
Why Is UNITEDHEALTH GROUP I (UNH) Stock Up Today?
By the Top Tier Newswire AI Desk · November 20, 2026 at 11:35 AM ET · reviewed against 23 wire stories
UNITEDHEALTH GROUP I (UNH) is up +5.02% in the latest session. Our newswire has captured 23 stories on UNH across 11 sources in the last 36 hours, with AI sentiment reading mixed (avg 53/100).
Public view, delayed 4h. Every headline, price and sentiment read below — and this write-up itself — reaches Pro subscribers live. Public readers see it once it clears the delay.
UnitedHealth Group (UNH) shares rose 5.02% to $347.08, driven primarily by an analyst upgrade from TD Cowen that lifted the stock to Buy with a $455 price target. The move follows a recent period of significant volatility, during which the stock had declined sharply due to concerns over proposed Medicare Advantage audit frameworks and fraud clawbacks.
What Happened
TD Cowen upgraded UnitedHealth Group and Humana to Buy ratings, citing an improved earnings outlook and a clearer path to profitability in the Medicare Advantage segment. The firm raised its price target for UnitedHealth to $455, while also lifting Humana’s target to $485. This analyst action provided immediate support to the stock, which had faced selling pressure earlier in the week following reports of a new Medicare for All proposal and a proposed CMS audit framework. The upgrade helped reverse some of the recent downward momentum, as the stock had fallen 18.4% over the previous eight sessions from $405.12 to $330.48.
What The Data Shows
The stock opened with a 1.5% gap up from the prior close of $330.48, reaching an intraday high of $347.45 at 11:30 AM ET. Trading volume reached 3.8 million shares, representing 0.7 times the three-month daily average. Options activity showed significant imbalance, with $559.9 million in put premium compared to $5.0 million in call premium across 27 notable prints, including a single large print of $137.8 million. Fundamental metrics show a market capitalization of $313.5 billion, a P/E ratio of 18.9, and a dividend yield of 2.65%. The stock’s 52-week range spans from $255.97 to $461.62. Recent filings indicate no insider buys in the last 90 days, with one sale by Optum CEO Patrick Hugh Conway totaling $456,000. Congressional disclosures show multiple sales by representatives including Maria Elvira Salazar, Kevin Hern, and Donald J. Trump in recent months.
What To Watch
Market participants will monitor the broader healthcare sector’s response to the proposed Medicare Advantage audit framework and any further regulatory developments regarding fraud clawbacks.
AI-assisted analysis composed exclusively from headlines and data on the Top Tier newswire. Public view is delayed 4 hours from real time. Not financial advice.
UNH · Nov 20 session (5-min) · +2.62% vs prior close · updated 3:39 PM ETAI sentiment, last 36h · averaged over 23 stories · 53/100 neutral
The headlines behind the move
Story flow · 8 stories on the wire, last 36h · hover or tap a dot for the headline
13h agoMarketWatchBEARISH 32General
Investors fled to healthcare stocks for safety. Now insurance and hospital shares are plunging.
Shares of UnitedHealth, Humana and CVS Health declined this week in light of a new Medicare for All proposal
14h agoInvesting.com MarketsBULLISH 66Analyst
TD Cowen lifts UnitedHealth, Humana to Buy on improved earnings outlook
TD Cowen lifts UnitedHealth, Humana to Buy on improved earnings outlook
14h agoInvesting.com MarketsBULLISH 62General
Why is UnitedHealth stock rallying today?
Why is UnitedHealth stock rallying today?
14h agoGuruFocusBULLISH 64Analyst
UNH Upgraded by TD Cowen -- Price Target Raised to $455
14h agoMarketWatchBULLISH 64General
Dow's 232-point rally led by gains for UnitedHealth, Home Depot stocks
15h agoGuruFocusBULLISH 68Analyst
UnitedHealth (UNH) Shares Rise After TD Cowen Upgrade and Target Price Boost
16h agoSeeking AlphaBULLISH 68Analyst
TD Cowen backs UnitedHealth & Humana with buy upgrades, shares rise
TD Cowen upgrades UnitedHealth and Humana to Buy, with targets of $455 and $485; it sees Humana above $40 EPS in 2028.
16h agoThe FlyBULLISH 64Analyst
Cowen Upgrades Unh And Hum Stocks To Buy And Lifts Price Targets After Healthcare Sell Off Heres Why
Want the next move before the crowd? The live terminal streams every headline in real time with watchlist alerts, AI sentiment, and the full data stack behind this page.Get Pro Access →